Purple biotech reports new preclinical data on potential of nt219 to re-sensitize resistant tumors to immune checkpoint inhibitors

New preclinical data from study presented at the american a ssociation for cancer research 2023 annual meeting , 18 april 2023

PPBT Ratings Summary

PPBT Quant Ranking